Project Details
Description
An Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine administered in Patients with B-cell Non-Hodgkin Lymphoma (NHL)
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/14 → 9/30/19 |
Funding
- ALOPEXX ONCOLOGY LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.